David Morrow is the Scientific Lead for Advanced Therapies at EATRIS, where he drives the scientific strategy for Advanced Therapy Medicinal Products (ATMP) and Vaccines, Inflammation and Immune Monitoring (VIIM). He plays a central role in building European networks of scientific and clinical expertise to address shared challenges in translating ATMPs to the clinic and contributes to multiple EU-funded collaborative projects.David earned a BSc in Molecular Biology from University College Dublin (2001) and a Ph.D. in Vascular Biology from Dublin City University (2006), followed by an American Heart Association Fellowship at the University of Rochester, NY, where he received the AHA Young Investigator Award (2008). From 2009–2015, he was a Principal Investigator funded by the NIH and AHA, leading translational projects in cardiovascular disease and oncology. He also holds an MBA in Health Science Management and has worked in consulting and technology transfer. David serves on several Scientific Advisory Boards and international initiatives in the ATMP field.